Effect ofN-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability-Reference-Cited by-同舟云学术

Effect ofN-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability

Published:1985-12 Issue:4 Volume:9 Page:365-373
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Magnusson Karl -Eric,Dahlgren Claes,Sj�Olander Anita

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF00916336.pdf

Reference32 articles.

1. Tomasi, T. B. Jr. 1976. The Immune System of Secretions. Prentice Hall, Englewood Cliffs, New Jersey.

2. Serrander, R., K.-E. Magnusson, andT. Sundqvist. 1984. Acute infections withGiardia lamblia and rotavirus decrease intestinal permeability to low-molecular-weight polyethylene glycols (PEG 400).Scand. J. Infect. Dis. 16:339?344.

3. Serrander, R., K.-E.Magnusson, E.Kihlström, and T.Sundqvist. Acute infections with Salmonellae and Yersiniae in man increase intestinal permeability towards low-molecular weight polyethylene glycols (PEG 400).Scand. J. Infect. Dis. (submitted).

4. Heuman, R., R. Sjödahl, andC. Tagesson. 1982. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethylene glycol 1000 in patients with Crohn's disease.Acta Chir. Scand. 148:281?284.

5. Magnusson, K.-E., T. Sundqvist, R. Sjödahl, andC. Tagesson, 1983. Altered intestinal permeability to low-molecular-weight polyethylene glycols (PEG 400) in patients with Crohn's disease.Acta Chir. Scand. 149:323?327.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Effects on Intestinal Functions;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Pharmacological Effects on Intestinal Functions;Drug Discovery and Evaluation: Pharmacological Assays;2014

3. Duodenitis-proximal jejunitis;Equine Veterinary Education;2010-01-05

4. Activity on the Gastrointestinal Tract;Drug Discovery and Evaluation;2007

5. Activity on the gastrointestinal tract1;Drug Discovery and Evaluation;2002